Machado, Alexandra
Pereira, Isabel
Costa, Filomena
Brandão, Ana
Pereira, José Eduardo
Maurício, Ana Colette
Santos, José Domingos
Amaro, Inês
Falacho, Rui
Coelho, Rui
Cruz, Nuno
Gama, Miguel http://orcid.org/0000-0002-5655-0015
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (SFRH/BD/132000/2017)
Universidade do Minho
Article History
Received: 2 March 2022
Accepted: 14 January 2023
First Online: 28 January 2023
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the Portuguese INFARMED and with the 1964 Helsinki Declaration or comparable ethical standards. iBone Therapies (European Databank on Medical Devices, EUDAMED, No. CIV-PT-18–01-02705; Protocol No. EC.01.01.17) was previously approved by the Portuguese National Authority of Medicines and Health Products, I.P. (INFARMED), after being submitted in the National Registry of Clinical Studies (RNEC, No. 30122), by the National Ethics Commission for Clinical Research (CEIC, RNEC No. 30121) and National Commission for the Protection of Data (CNPD).
: Informed consent was obtained from all individual participants included in the study. Research participants also provided informed consent regarding the publication of every information included in the present manuscript.
: The authors declare no competing interests.